Evidence map›Paper›PMID 28669576›Full record

ReviewTrends in genetics : TIG2017

Histone H2A Monoubiquitination in Neurodevelopmental Disorders.

Anshika Srivastava, Brian McGrath, Stephanie L Bielas

Abstract readReview
In one paragraph

Review in Trends in genetics : TIG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Atypical Ubiquitination and Parkinson's Disease.International journal of molecular sciences · 2022
    Review
  14. Insights in Post-Translational Modifications: Ubiquitin and SUMO.International journal of molecular sciences · 2022
    Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Modeling Bainbridge-Ropers Syndrome inFrontiers in physiology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anshika SrivastavaDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA.
Brian McGrathCell and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI, USA.
Stephanie L BielasDepartment of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, USA; Cell and Molecular Biology Program, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: sbielas@umich.edu.

Funding

CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Role of histone ubiquitination in neurodevelopment and diseaseR01NS101597 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BIELAS, STEPHANIE LEE · 2018 to 2022
$2.0M
Neurogenesis: Career Development Plan in the Genetic and Modeling of MicrocephalyR00HD069624 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BIELAS, STEPHANIE LEE · 2013 to 2015
$691k
Genetic Diagnosis of Heritable Neurodevelopmental Disorders with Exome SequencingR21NS094047 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BIELAS, STEPHANIE LEE · 2015 to 2016
$341k
NICHD NIH HHS R00 HD069624NIGMS NIH HHS T32 GM007315NINDS NIH HHS R01 NS101597NINDS NIH HHS R21 NS094047
6 · The paper itself

Abstract

Covalent histone modifications play an essential role in gene regulation and cellular specification required for multicellular organism development. Monoubiquitination of histone H2A (H2AUb1) is a reversible transcriptionally repressive mark. Exchange of histone H2A monoubiquitination and deubiquitination reflects the succession of transcriptional profiles during development required to produce cellular diversity from pluripotent cells. Germ-line pathogenic variants in components of the H2AUb1 regulatory axis are being identified as the genetic basis of congenital neurodevelopmental disorders. Here, we review the human genetics findings coalescing on molecular mechanisms that alter the genome-wide distribution of this histone modification required for development.

Indexed as

HistonesHumansNeurodevelopmental DisordersPolycomb-Group ProteinsUbiquitinationHistonesPolycomb-Group Proteinshistone monoubiquitinationneurodevelopment disordersneurogeneticsPolycomb repression

Identifiers

PMID28669576
PMCPMC5562288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.